drugset / Trial / NCT02903030

Probiotics for Quality of Life in Autism Spectrum Disorders

NCT02903030 ↗

RandomizedCrossoverTriple-blindTreatment

Summary

A randomized pilot trial of a probiotic for quality of life in autism spectrum disorder (ASD), targeting gastrointestinal (GI) symptoms.

Timeline

Start
2016-08
Primary completion
2017-12-01
Completion
2017-12-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Visbiome Extra Strength Other / unclassified — —